LapSpace Medical

Company Overview

Snapshot

Founded in December 2011, LapSpace Medical operated with 1-10 employees. The company ceased operations in September 2020, following its launch of a novel surgical device in the US market in October 2014.

Business overview

LapSpace Medical develops medical devices for laparoscopic procedures within the Health Tech & Life Sciences sector. The company's core product is an inflatable balloon retractor designed to efficiently retract organs during surgery, creating a stable operating field. This technology aims to improve surgical efficiency and reduce costs by allowing the device to remain in place without additional personnel. LapSpace Medical serves the medical device market, particularly within hospitals and surgical settings, focusing on gastroenterology, laparoscopy, and gynecology.

Strategic signal

LapSpace Medical ceased operations in September 2020. This indicates a complete halt in business activities, signaling to investors and innovation teams that the company is no longer an active entity in the medical device market.

Company Intelligence Q&A

What is the primary product developed by LapSpace Medical?

LapSpace Medical developed an inflatable balloon retractor for laparoscopic procedures, designed to provide efficient retraction of organs and create a stable operating field.

When did LapSpace Medical cease operations?

LapSpace Medical ceased to operate in September 2020.

When did LapSpace Medical launch its surgical device in the US market?

In October 2014, LapSpace Medical rolled out its novel surgical device for laparoscopic surgery in the US market.

Which investors participated in LapSpace Medical's funding round?

In November 2013, LapSpace Medical secured funding from The Trendlines Group and the Office of the Chief Scientist.

What regulatory clearance did LapSpace Medical's device receive?

LapSpace Medical's inflatable laparoscopic retractor received FDA clearance, allowing its launch in the US market.